Short-Term Debt to Capital: Ainos Inc (AIMD)

Brandmark of Ainos, Inc. (AIMD)

Ainos, Inc. (AIMD) develops innovative sensors for respiratory diagnostics, monetizing the sale of consumables through patent protection. The firm's environmental strategy focuses on reagent recycling and plastic reduction. The business relies on AI medicine and rapid tests, ensuring sustainable diversification. The current metric is 4.54, and the price trend reflected below demonstrates the dynamics of debt obligations and equity.

AIMD - Ainos Corp Short-Term Debt to Capital over the range 04/28/2023 - 10/31/2026

Analytical breakdowns for Ainos, Inc.

- stock quotes and analyst forecast:
Stock Price Ainos Corp|AIMD - Average Forecast Price
- company stock exchange capitalization indicators:
Market Capitalization Ainos Inc|AIMD - Business Value
- book capitalization information:
Book Value per Share Ainos|AIMD - Book Capitalization|Market Value to Book Value Ratio ainos.com|AIMD - Total Business Assets
- business debt structure and liquidity details:
Total Debt to Capital Ainos, Inc.|AIMD - Long-Term Debt to Capital|Short-Term Debt to Equity Ainos|AIMD - Company Debts|Debt to Book Value Ainos Inc|AIMD - Long-Term Debt|Company Short-Term Debt Ainos|Quick Ratio ainos.com
- earnings and market ratios statistics:
AIMD - Net Financial Result
General company analysis:Ainos Corp AIMD
Brand item of Ainos

Ainos, Inc. development of portable tests to reduce environmental impact requires flexible financing; therefore, changes in the share of short-term liabilities within the capital structure reflect the company's reliance on operational loans. This metric measures the pressure of current costs and inflation on net income, allowing investors to assess the risk of margin compression or, conversely, the efficiency of utilizing short-term resources to accelerate business expansion.

Competitors of Ainos, Inc. (AIMD)

Short-Term Debt to Capital A|DGX - Current Liabilities to Capital|Short-Term Debt to Capital ILMN (Illumina, Inc.)|EXAS: Short-Term Debt to Capital Ratio|Revvity - Short-Term Debt to Capital|BIO - Short-Term Debt to Capital|Anbio Tech (NNNN) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio SHC|QDEL (QuidelOrtho) - Short-Term Debt to Capital|Short-Term Debt to Capital opko.com|Short-Term Debt to Equity CareDx Health (CDNA)|Short-Term Debt to Equity MRVI (Maravai LifeSciences Holdings)|Fulgent Corp - Short-Term Debt to Equity Ratio|Standard BioTools Corp (LAB) - Current Liabilities to Capital|CTKB - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient orasure.com OSUR|XGN: Short-Term Debt to Capital|MDXH - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Lucid Diagnostics Inc|Prenetics Global Ltd (PRE) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital IMDX|Short-Term Debt to Capital trinitybiotech.com (TRIB)|Short-Term Debt to Capital PRPH (ProPhase Labs)|Short-Term Debt to Capital Coefficient Co-Diagnostics Inc (CODX)|HSCS - Short-Term Debt to Equity|BMRA (Biomerica Inc) - Short-Term Debt to Capital Ratio|cardiodiagnosticsinc.com (CDIO) - Short-Term Debt to Equity|Current Liabilities to Capital viraxbiolabs.com (VRAX)|Short-Term Debt to Equity Bluejay Diagnostics, Inc.|Aspira Women's Health, Inc. (AWH) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio AXDX (Accelerate Diagnostics, Inc)|CNTG (Centogene) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ENZ (Enzo Biochem)|Short-Term Debt to Capital Coefficient Fresh2 Group Ltd (FRES)|GENE - Short-Term Debt to Equity|ME (23andMe Holding Co) - Short-Term Debt to Capital Ratio|PMD: Short-Term Debt to Capital